The metabolic syndrome using the National Cholesterol Education Program and International Diabetes Federation definitions among urbanised black South Africans with established coronary artery disease

被引:6
|
作者
Ntyintyane, Lucas M. [1 ]
Panz, Vanessa R. [1 ]
Raal, Frederick J. [1 ]
Gill, Geoffrey V. [2 ]
机构
[1] Univ Witwatersrand, Dept Med, Carbohydrate & Lipid Metab Res Unit, Johannesburg, South Africa
[2] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England
关键词
D O I
10.1080/22201009.2007.10872151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The International Diabetes Federation (IDF) introduced a new definition of the metabolic syndrome (MS) that emphasises ethnic-specific cut-offs for waist circumference (WC). Objective. To compare MS prevalence rates using the National Cholesterol Education Program Adult Treatment Panel III (NCEP: ATP III) and IDF definitions. Methods. Anthropometric data, fasting biochemical variables and MS prevalence rates were measured in 40 black patients with established coronary artery disease (CAD). Glucose metabolism was assessed using the oral glucose tolerance test (OGTT), and insulin-mediated glucose disposal (M-value) was evaluated using the hyperinsulinaemic euglycaemic clamp technique. Results. Based on the NCEP: ATP III definition, MS prevalence was 60% and using the IDF definition, it was 57.5%. The two definitions similarly classified similar to 83% of patients as being MS positive or MS negative. Lower WC cut-offs in the IDF definition classified greater numbers of men and women as having WC as a risk factor -IDF v. NCEP: ATP III men 57.6% v. 36.4%; women 100% v. 71.4%. Impaired glucose tolerance (IGT) was found in 12 of the 40 patients (30%) and diabetes mellitus (DM) in 8 (20%). Mean M-value was reduced in IGT and DM groups compared with the normal group, significantly so in the DM group (p = 0.01). Conclusions. NCEP: ATP III and IDF definitions both generated similar MS prevalence estimates. The two definitions similarly identified the presence or absence of the MS in the majority of patients. The IDF definition classified greater numbers of men and women as having WC as a risk factor. There was a high prevalence of previously undiagnosed IGT and DM in our South African black patients with established CAD.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 44 条
  • [41] National cholesterol education program expert panel (Adult Treatment Panel III) definition of the metabolic syndrome fails to identify homogeneous subgroups of patients at risk for cardiovascular disease and type 2 diabetes
    St-Pierre, AC
    Bossé, Y
    Pérusse, L
    Bouchard, C
    Tremblay, A
    Després, JP
    Vohl, MC
    Lamarche, B
    [J]. CIRCULATION, 2003, 108 (17) : 734 - 734
  • [42] Association between high-sensitive measurement of C-reactive protein and metabolic syndrome as defined by International Diabetes Federation, National Cholesterol Education Program, and World Health Organization criteria in a population-based cohort of 55-year-old Finnish individuals
    Hirsso, Paivi K.
    Timonen, Markku J.
    Jokelainen, Jari J.
    Hiltunen, Liisa A.
    Laakso, Mauri A.
    Hedberg, Pirjo S. M.
    Ruokonen, Aimo O.
    Koskela, Pentti
    Harkonen, Pirjo K.
    Keinanen-Kiukaanniemi, Sirkka M.
    Rajala, Ulla M.
    [J]. DIABETES CARE, 2006, 29 (09) : 2177 - 2178
  • [43] Assessment of two different diagnostic guidelines criteria (National Cholesterol Education Adult Treatment Panel III [ATP III] and International Diabetes Federation [IDF]) for the evaluation of metabolic syndrome remission in a longitudinal cohort of patients undergoing Roux-en-Y gastric bypass
    Rodriguez-Ortiz, Donaji
    Reyes-Perez, Azucena
    Leon, Pablo
    Sanchez, Hugo
    Mosti, Maureen
    Aguilar-Salinas, Carlos A.
    Velazquez-Fernandez, David
    Herrera, Miguel F.
    [J]. SURGERY, 2016, 159 (04) : 1121 - 1128
  • [44] Efficacy of orlistat plus lifestyle changes in risk reduction of Type 2 diabetes in obese patients with metabolic syndrome -: a comparative analysis using national cholesterol education program Adult Treatment Panel III vs European group for the study of insulin resistance criteria
    Torgerson, JS
    Hauptman, J
    Boldrin, M
    Sjöström, L
    [J]. DIABETOLOGIA, 2004, 47 : A249 - A250